Life Sentence Handed Down In Fatal Counterfeit Diabetes Drug Case
This article was originally published in PharmAsia News
Executive SummaryThe Kashgar District Intermediate People's Court recently sentenced eight defendants to prison time and fines for the manufacture and sale of counterfeit "glycolipid capsules" that resulted in the deaths of two diabetic patients in 2009
You may also be interested in...
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.